Ontario, Canada, March 9th, 2019 – Kensana Health (“Kensana” or the “Company“) is pleased to announce that it has completed the funding of its Series A financing round of $6.8-Million USD with strategic partner Martin Bauer Holding (MBH). MBH has acquired an 18% stake in the Company for a post-money valuation of $46.8-Million USD.
MBH is a group of 20 companies operating globally under the Nature Network® banner. The Nature Network® is one of the largest extractors of GMP pharmaceutical plant APIs in the world. The company was founded in 1930 and remains family run (fourth generation). Today, the Nature Network has more than 3,500 employees with 20 companies worldwide and annual turnover of more than €550M.
